Your Position: Home > Chemicals > Introduction to CAS 2381089-83-2 LY3437943 Wholesale high purity
Guest Posts

Introduction to CAS 2381089-83-2 LY3437943 Wholesale high purity

Author:

CC

Nov. 09, 2023
  • 135
  • 0

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

Introduction to CAS 2381089-83-2 LY3437943 Wholesale high purity

 

Common NameLY3437943
CAS Number2381089-83-2Molecular Weight4731.33
DensityN/ABoiling PointN/A
Molecular FormulaC221H342N46O68Melting PointN/A
MSDSN/AFlash PointN/A

Chemical & Physical Properties

Molecular FormulaC221H342N46O68
Molecular Weight4731.33

 

LY3437943 Biological Activity

DescriptionLY3437943 is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). LY3437943 inhibits for human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. LY3437943 can be used for the research of obesity[1].
Related Catalog

Research Areas >> Metabolic Disease

Target

EC50 (for human): 5.79 (GCGR), 0.0643 (GIPR), 0.775 nM (GLP-1R) [1]. EC50 (for mouse): 2.32 (GCGR), 0.191 (GIPR), 0.794 nM (GLP-1R) [1]. Ki (for human): 5.6 (GCGR), 0.057 (GIPR), 7.2 nM (GLP-1R) [1]. Ki (for mouse): 73 (GCGR), 2.8 (GIPR), 1.3 nM (GLP-1R)[1].

In VitroLY3437943 has inhibition for human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively[1]. LY3437943 has inhibition for mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively[1]. LY3437943 has binding affinity for human GCGR, GIPR, and GLP-1R with Ki values of 5.6, 0.057 and 7.2 nM, respectively[1]. LY3437943 has binding affinity for mouse GCGR, GIPR, and GLP-1R with Ki values of 73, 2.8 and 1.3 nM, respectively[1].
In VivoLY3437943 (s.c.; 0.47 mg/kg; single) engages GCGR in vivo and can improve glucose tolerance in an ipGTT through either the GIP or GLP-1 receptors[1]. LY3437943 (s.c.; 10 mL/kg; cycle every 3 days; for 21 days) causes great body weight loss and increases energy expenditure through glucagon receptor activatio[1]. LY3437943 has safety and tolerability[1]. Animal Model: Male CD-1 mice[1] Dosage: 0.47 mg/kg Administration: Subcutaneous administration, single Result: AUClast, ng*h/mL AUC0-∞, ng*h/mL Cmax, ng/mL Tmax, h t1/2, h CLF, mL/h/kg 41135 41905 1680 12 21 11.22 Animal Model: Diet-induced obese (DIO) male C57/Bl6 mice (24-25 weeks, 40-51 g)[1] Dosage: 10 mL/kg Administration: Subcutaneous (SC) injection, cycle every 3 days, for 21 days Result: Decreased body weight and improved glycemic control.
References

[1]. Tamer Coskun, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metab. 2022 Sep 6;34(9):1234-1247.e9.

Product details:

 

CAS 2381089-83-2 LY3437943 Wholesale high purity

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS 188111-79-7 (R)-1-Boc-3-Aminopiperidine Safe delivery

 

CAS 910463-68-2 Semaglutide acetate salt  High purity

 

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

 

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

 

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

 

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS

Name

326-59-0

1,3-Benzodioxole-5-aceticacid, methyl ester

1451-82-7

2-Bromo-4'-methylpropiophenone

79099-07-3

N-(tert-Butoxycarbonyl)-4-piperidone

19099-93-5

N-CBZ-4-piperidone

288573-56-8

tert-butyl 4-(4-fluoroanilino)piperidine-1-carboxylate

23076-35-9

Xylazine hydrochloride

5413-05-8

Ethyl 3-oxo-4-phenylbutanoate

29878-31-7

4-METHYL-1H-BENZO[D][1,2,3]TRIAZOLE

 

2732926-24-6

1H-Benzimidazole-1-ethanamine,N-ethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-

20320-59-6

Diethyl(phenylacetyl)malonate

91393-49-6

2-(2-chlorophenyl)cyclohexanone

49851-31-2

2-Bromo-1-phenyl-1-pentanone

102-97-6

Benzylisopropylamine

7361-61-7

Xylazine

110-63-4

1,4-Butanediol

718-08-1

Ethyl 3-oxo-4-phenylbutanoate

54123-15-8

Fluclotizolam

1193389-70-6

(4-Fluoro-phenyl)-piperidin-4-yl-amine dihydrochloride

236117-38-7

2-iodo-1-p-tolylpropan-1-one

80532-66-7

methyl-2-methyl-3-phenylglycidate

28281-49-4

3,4-Methylenedioxyphenyl ethyl ketone

171596-29-5

Cialis

2023788-19-2

Tirzepatide

98977-36-7

1-Boc-3-Piperidinone

66981-73-5

Tianeptine

30123-17-2

Tianeptine Sodium Salt

74163-84-1

Troparil

62-44-2

Phenacetin

69673-92-3

2-Chloro-1-(4-Methylphenyl)-1-Propanone

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

 

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

 

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

CAS 191790-79-1 2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester

 

Exhibition hall:

Share:

Comments

0/2000

Get in Touch